Results 1 - 10 of 964

< 1 2 3 ... 96 97 >

• Charles M. Marson. New and unusual scaffolds in medicinal chemistry, Chem. Soc. Rev., 2011, 40, 5514.

  [DOI: 10.1039/c1cs15119c]
  
• Changyang Gong, Tao Yang, Xiaoyan Yang, Yuanyuan Liu, Wei Ang, Jianying Tang, Weiyi Pi, Li Xiong, Ying Chang, WeiWei Ye, Zhenling Wang, Youfu Luo, Xia Zhao and Yuquan Wei. Carrier-free nanoassemblies of a novel oxazolidinone compound FYL-67 display antimicrobial activity on methicillin-resistant Staphylococcus aureus, Nanoscale, 2013, 5, 275.

  [DOI: 10.1039/c2nr32505e]
  
• X. Yang, Z. Li, Z. Wang, Z. Sang, H. Long, J. Tang, et al.. 6

  [DOI: 10.1039/C5MD00101C]
  
• Head BM; Rubinstein E; Meyers AF. Alternative pre-approved and novel therapies for the treatment of anthrax., BMC infectious diseases

  [PubMed: 27809794]
  [DOI: 10.1186/s12879-016-1951-y]
  
• Santos A; Cremades R; Rodr?guez JC; Garcia-Pachon E; Ruiz M; Royo G. Activity of various drugs alone or in combination against Mycobacterium fortuitum., Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

  [PubMed: 20063030]
  [DOI: 10.1007/s10156-009-0008-1]
  
• Udo EE; Al-Sweih N; Mokaddas E; Johny M; Dhar R; Gomaa HH; Al-Obaid I; Rotimi VO. Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004., BMC infectious diseases

  [PubMed: 17125522]
  [DOI: 10.1186/1471-2334-6-168]
  
• Paiva JA; Eggimann P. Treatment of severe MRSA infections: current practice and further development., Intensive care medicine

  [PubMed: 27704152]
  [DOI: 10.1007/s00134-016-4572-4]
  
• McCool R; Gould IM; Eales J; Barata T; Arber M; Fleetwood K; Glanville J; Kauf TL. Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA., BMC infectious diseases

  [PubMed: 28061827]
  [DOI: 10.1186/s12879-016-2100-3]
  
• Matono T; Hayakawa K; Hirai R; Miyoshi-Akiyama T; Tanimura A; Yamamoto K; Fujiya Y; Mawatari M; Kutsuna S; Takeshita N; Mezaki K; Ohmagari N. Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy., BMC research notes

  [PubMed: 27036708]
  [DOI: 10.1186/s13104-016-2003-9]
  
• Schrenk KG; Frosinski J; Scholl S; Otto S; La Ros?e P; Hochhaus A; Pletz MW. Successful treatment of neutropenic MRSA bacteremia with septic superior vena cava thrombus and cerebral embolism using high-dose daptomycin., Annals of hematology

  [PubMed: 26490881]
  [DOI: 10.1007/s00277-015-2526-5]